Gabriel Q Shaibi1, Michael I Goran. 1. College of Nursing and Healthcare Innovation, Arizona State University, Phoenix, Arizona, USA.
Abstract
OBJECTIVE: To examine the prevalence of the metabolic syndrome in overweight Hispanic youth according to 3 published pediatric definitions. Furthermore, the relationship of each definition to directly measured insulin resistance was examined. STUDY DESIGN: We conducted a secondary data analysis of 218 overweight Hispanic youth with a family history of type 2 diabetes mellitus. The metabolic syndrome was defined as >/=3 of these criteria: elevated triglyceride level, low high-density lipoprotein cholesterol level, elevated blood pressure, abdominal obesity, and hyperglycemia. The cutoff points were derived from updated definitions of Cook et al,(1) Cruz et al,(2) and Weiss et al.(3) Insulin sensitivity was determined with the insulin-modified frequently sampled intravenous glucose tolerance test. RESULTS: Prevalence of the metabolic syndrome ranged from 25.7% to 39%, with moderate to substantial agreement between definitions (kappa = 0.52-0.70). Regardless of definition, an inverse relationship between metabolic risk and insulin sensitivity was noted such that children with the metabolic syndrome had 51% to 60% lower insulin sensitivity compared with children without any risk factors (P </=.001 for all definitions). CONCLUSION: The metabolic syndrome is prevalent in overweight Hispanic youth and may provide pediatricians with additional clinical insight for identifying the most metabolically at-risk children. Working toward a uniform and practical definition of the metabolic syndrome may improve its clinical implementation.
OBJECTIVE: To examine the prevalence of the metabolic syndrome in overweight Hispanic youth according to 3 published pediatric definitions. Furthermore, the relationship of each definition to directly measured insulin resistance was examined. STUDY DESIGN: We conducted a secondary data analysis of 218 overweight Hispanic youth with a family history of type 2 diabetes mellitus. The metabolic syndrome was defined as >/=3 of these criteria: elevated triglyceride level, low high-density lipoprotein cholesterol level, elevated blood pressure, abdominal obesity, and hyperglycemia. The cutoff points were derived from updated definitions of Cook et al,(1) Cruz et al,(2) and Weiss et al.(3) Insulin sensitivity was determined with the insulin-modified frequently sampled intravenous glucose tolerance test. RESULTS: Prevalence of the metabolic syndrome ranged from 25.7% to 39%, with moderate to substantial agreement between definitions (kappa = 0.52-0.70). Regardless of definition, an inverse relationship between metabolic risk and insulin sensitivity was noted such that children with the metabolic syndrome had 51% to 60% lower insulin sensitivity compared with children without any risk factors (P </=.001 for all definitions). CONCLUSION: The metabolic syndrome is prevalent in overweight Hispanic youth and may provide pediatricians with additional clinical insight for identifying the most metabolically at-risk children. Working toward a uniform and practical definition of the metabolic syndrome may improve its clinical implementation.
Authors: Hyun-Sik Kang; Bernard Gutin; Paule Barbeau; Scott Owens; Christian R Lemmon; Jerry Allison; Mark S Litaker; Ngoc-Anh Le Journal: Med Sci Sports Exerc Date: 2002-12 Impact factor: 5.411
Authors: Cynthia L Ogden; Robert J Kuczmarski; Katherine M Flegal; Zuguo Mei; Shumei Guo; Rong Wei; Laurence M Grummer-Strawn; Lester R Curtin; Alex F Roche; Clifford L Johnson Journal: Pediatrics Date: 2002-01 Impact factor: 7.124
Authors: William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan Journal: N Engl J Med Date: 2002-02-07 Impact factor: 91.245
Authors: K M Venkat Narayan; James P Boyle; Theodore J Thompson; Stephen W Sorensen; David F Williamson Journal: JAMA Date: 2003-10-08 Impact factor: 56.272
Authors: Peter T Katzmarzyk; Arthur S Leon; Jack H Wilmore; James S Skinner; D C Rao; Tuomo Rankinen; Claude Bouchard Journal: Med Sci Sports Exerc Date: 2003-10 Impact factor: 5.411
Authors: Daniel J Lesser; Rajeev Bhatia; Winston H Tran; Flavia Oliveira; Ricardo Ortega; Thomas G Keens; Steven D Mittelman; Michael C K Khoo; Sally L Davidson Ward Journal: Pediatr Res Date: 2012-06-05 Impact factor: 3.756
Authors: Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel Journal: Endocr Rev Date: 2008-10-29 Impact factor: 19.871
Authors: Francine R Kaufman; Kathryn Hirst; Barbara Linder; Tom Baranowski; Dan M Cooper; Gary D Foster; Linn Goldberg; Joanne S Harrell; Marsha D Marcus; Roberto P Treviño Journal: Diabetes Care Date: 2009-02-05 Impact factor: 17.152
Authors: Connie L Tompkins; William Cefalu; Eric Ravussin; Michael Goran; Arlette Soros; Julia Volaufova; Alfonso Vargas; Melinda S Sothern Journal: Int J Pediatr Obes Date: 2010
Authors: Mercedes Gil-Campos; Maria del Carmen Ramírez-Tortosa; Elvira Larqué; Javier Linde; Concepción M Aguilera; Ramón Cañete; Angel Gil Journal: Lipids Date: 2008-07-01 Impact factor: 1.880